Drug Class
BCMA-directed CD3 bispecific antibody
Type
brand
Active Ingredient
teclistamab
📋Overview
Tecvayli is a monoclonal antibody used in the management of certain blood cancers, specifically multiple myeloma. It works by targeting proteins found on the surface of cancerous plasma cells, helping the immune system recognize and attack these cells. Tecvayli is typically considered in cases where other treatments have not been effective. Its use is associated with advanced or relapsed forms of multiple myeloma.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Tecvayli
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.